Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Advances in Diagnostic and Treatment Research in Sports Concussion
Videos
Advances in Diagnostic and Treatment Research in Sports Concussion
11/02/2020
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for concussion, and more. She recently...
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for concussion, and more. She recently...
In this video, Christina L....
11/02/2020
Neurology

Advertisement

Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Key Clinical Takeaways
Videos
Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Key Clinical Takeaways
11/01/2020
In this video, Laura T. Safar, MD, addresses the impact of neuropsychiatric disorders on quality of life among patients with multiple sclerosis, and the importance of monitoring the prevalence of depression, anxiety, and cognitive disorders...
In this video, Laura T. Safar, MD, addresses the impact of neuropsychiatric disorders on quality of life among patients with multiple sclerosis, and the importance of monitoring the prevalence of depression, anxiety, and cognitive disorders...
In this video, Laura T. Safar,...
11/01/2020
Neurology
MS and COVID-19: The Pros and Cons of Telemedicine
Videos
MS and COVID-19: The Pros and Cons of Telemedicine
10/27/2020
In this video, Florian Thomas, MD, discusses the use of telemedicine among patients with multiple sclerosis during the ongoing pandemic, and what can and cannot be accomplished in a telemedicine visit.
In this video, Florian Thomas, MD, discusses the use of telemedicine among patients with multiple sclerosis during the ongoing pandemic, and what can and cannot be accomplished in a telemedicine visit.
In this video, Florian Thomas,...
10/27/2020
Neurology
Managing Migraine During COVID-19: Treatment Challenges
Videos
Managing Migraine During COVID-19: Treatment Challenges
10/23/2020
In this video, Regina Krel, MD, discusses challenges that arose during the pandemic when it came to administering migraine treatments to her patients, especially during the shelter-in-place order in New Jersey, and how she overcame these...
In this video, Regina Krel, MD, discusses challenges that arose during the pandemic when it came to administering migraine treatments to her patients, especially during the shelter-in-place order in New Jersey, and how she overcame these...
In this video, Regina Krel, MD,...
10/23/2020
Neurology

Advertisement

Bridging Knowledge Gaps in Sports Concussion Prevention and Treatment: Evidence for Rule Changes and More
Videos
Bridging Knowledge Gaps in Sports Concussion Prevention and Treatment: Evidence for Rule Changes and More
10/23/2020
In this video, Christina L. Master, MD, reviews evidence of the role of rule changes in preventing concussion in hockey and football, research on active rehabilitation in the treatment of concussion, and more. She recently discussed these...
In this video, Christina L. Master, MD, reviews evidence of the role of rule changes in preventing concussion in hockey and football, research on active rehabilitation in the treatment of concussion, and more. She recently discussed these...
In this video, Christina L....
10/23/2020
Neurology
Managing Migraine During COVID-19: Impact on Patients
Videos
Managing Migraine During COVID-19: Impact on Patients
10/21/2020
In this video, Regina Krel, MD, discusses the emotional impact of the ongoing pandemic on her patients with migraine.
In this video, Regina Krel, MD, discusses the emotional impact of the ongoing pandemic on her patients with migraine.
In this video, Regina Krel, MD,...
10/21/2020
Neurology
Videos
Erenumab: A Game-Changer for Chronic Migraine With or Without Acute Medication Overuse
10/20/2020
In this video, Stewart Tepper, MD, discusses the findings from his recent trial on the long-term efficacy of erenumab among patients with chronic migraine with or without acute medication overuse, and how erenumab has changed the way he...
In this video, Stewart Tepper, MD, discusses the findings from his recent trial on the long-term efficacy of erenumab among patients with chronic migraine with or without acute medication overuse, and how erenumab has changed the way he...
In this video, Stewart Tepper,...
10/20/2020
Neurology

Advertisement

MS and COVID-19: The Use of Disease-Modifying Therapies
Videos
MS and COVID-19: The Use of Disease-Modifying Therapies
10/19/2020
In this video, Florian Thomas, MD, discusses the use of disease-modifying therapies among patients with multiple sclerosis during the ongoing pandemic.
In this video, Florian Thomas, MD, discusses the use of disease-modifying therapies among patients with multiple sclerosis during the ongoing pandemic.
In this video, Florian Thomas,...
10/19/2020
Neurology
Michelle Monje, MD, PhD, Discusses the Neuronal Regulation of the Pathobiology of Brain Tumors
Videos
Michelle Monje, MD, PhD, Discusses the Neuronal Regulation of the Pathobiology of Brain Tumors
10/12/2020
In this video, Dr Monje discusses recent evidence regarding the neuronal regulation of the pathobiology of brain tumors and potential implications of this evidence. Dr Monje was presented with an award for this talk at the American...
In this video, Dr Monje discusses recent evidence regarding the neuronal regulation of the pathobiology of brain tumors and potential implications of this evidence. Dr Monje was presented with an award for this talk at the American...
In this video, Dr Monje...
10/12/2020
Neurology
Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Interdisciplinary Treatment Is Key
Videos
Neuropsychiatric Disorders Among Patients With Multiple Sclerosis: Interdisciplinary Treatment Is Key
10/06/2020
In this video, Laura T. Safar, MD, details the importance of regular, interdisciplinary collaboration between neurologists, psychiatrists, and other clinicians in the treatment of patients with multiple sclerosis and comorbid neuropsychiatric...
In this video, Laura T. Safar, MD, details the importance of regular, interdisciplinary collaboration between neurologists, psychiatrists, and other clinicians in the treatment of patients with multiple sclerosis and comorbid neuropsychiatric...
In this video, Laura T. Safar,...
10/06/2020
Neurology

Advertisement

Advertisement

Advertisement

News

Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use